Literature DB >> 29541431

Health Care of Elderly: A Viewpoint in Terms of Economic Evaluation.

Suguna Anbazhagan1, A Surekha1.   

Abstract

Entities:  

Year:  2018        PMID: 29541431      PMCID: PMC5843952          DOI: 10.4103/ijpvm.IJPVM_357_16

Source DB:  PubMed          Journal:  Int J Prev Med        ISSN: 2008-7802


× No keyword cloud information.
Dear Editor, One of the major factors driving the cost of healthcare upward in developing countries is aging population.[1] Policy makers and health-care providers face the challenge of optimally allocating scarce health-care resources over competing alternatives for elderly population. Research work has been conducted in India depicting the quality-adjusted life years (QALYs) of the elderly population within the context of various therapeutic areas;[23] however, there is a lack of research which specifically assesses the cost-effectiveness of health care for the elderly. While QALYs represent the most acceptable outcome for use in an economic evaluation, we also need to look at the measures which capture the benefits of health and social care interventions for the well-being of older people. Since elderly are more prone for diseases such as diabetes mellitus and hypertension, the economic burden of these diseases is also expected to be greater in such population.[4] In such context, economic evaluation indicates that the addition of pharmaceutical care in the core health team will not increase total direct health costs, yet will improve the health outcomes.[5] Heart failure among elderly poses such significant financial burden that efficient resource allocation for its diagnosis and treatment is a major societal and governmental challenge. Cost-effectiveness of falls prevention strategies has been done[6] but not in an Indian setting. It is also time to establish the cost-utility of minimal psychological interventions and also vaccinations for elderly persons.[7] To conclude, since economic evaluations can support policy makers for the optimal allocation of health and social care resources within limited budgets, there is a need for well-designed reliable economic evaluation research for healthcare of elderly in particular, to support decision-making on the long-term financing and planning of these programs.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  6 in total

1.  Importance of Economic Evaluation in Health Care: An Indian Perspective.

Authors:  Amit Dang; Nishkarsh Likhar; Utkarsh Alok
Journal:  Value Health Reg Issues       Date:  2016-02-10

2.  Economic evaluation of a pharmaceutical care program for elderly diabetic and hypertensive patients in primary health care: a 36-month randomized controlled clinical trial.

Authors:  Paulo Roque Obreli-Neto; Srecko Marusic; Camilo Molino Guidoni; André de Oliveira Baldoni; Rogério Dias Renovato; Diogo Pilger; Roberto Kenji Nakamura Cuman; Leonardo Régis Leira Pereira
Journal:  J Manag Care Spec Pharm       Date:  2015-01

3.  Global burden of hypertension: analysis of worldwide data.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

4.  Evaluating the cost-effectiveness of fall prevention programs that reduce fall-related hip fractures in older adults.

Authors:  Kevin D Frick; Jacquelyn Y Kung; John M Parrish; Matthew J Narrett
Journal:  J Am Geriatr Soc       Date:  2010-01       Impact factor: 5.562

5.  Economic evaluation of standing order programs for pneumococcal vaccination of hospitalized elderly patients.

Authors:  Donald B Middleton; Chyongchiou J Lin; Kenneth J Smith; Richard K Zimmerman; Mary Patricia Nowalk; Mark S Roberts; Dwight E Fox
Journal:  Infect Control Hosp Epidemiol       Date:  2008-05       Impact factor: 3.254

6.  Cost-effectiveness analysis of three different combinations of inhalers for severe and very severe chronic obstructive pulmonary disease patients at a tertiary care teaching hospital of South India.

Authors:  Mohammed Altaf; Ayesha Mubeen Zubedi; Fareesa Nazneen; Shaik Kareemulla; Syed Amir Ali; N M Aleemuddin; Md Abdul Hannan Hazari
Journal:  Perspect Clin Res       Date:  2015 Jul-Sep
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.